These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31963488)
1. Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision? Noskova H; Kyr M; Pal K; Merta T; Mudry P; Polaskova K; Ivkovic TC; Adamcova S; Hornakova T; Jezova M; Kren L; Sterba J; Slaby O Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963488 [TBL] [Abstract][Full Text] [Related]
2. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. Merino DM; McShane LM; Fabrizio D; Funari V; Chen SJ; White JR; Wenz P; Baden J; Barrett JC; Chaudhary R; Chen L; Chen WS; Cheng JH; Cyanam D; Dickey JS; Gupta V; Hellmann M; Helman E; Li Y; Maas J; Papin A; Patidar R; Quinn KJ; Rizvi N; Tae H; Ward C; Xie M; Zehir A; Zhao C; Dietel M; Stenzinger A; Stewart M; Allen J; J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217756 [TBL] [Abstract][Full Text] [Related]
3. Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels. Endris V; Buchhalter I; Allgäuer M; Rempel E; Lier A; Volckmar AL; Kirchner M; von Winterfeld M; Leichsenring J; Neumann O; Penzel R; Weichert W; Glimm H; Fröhling S; Winter H; Herth F; Thomas M; Schirmacher P; Budczies J; Stenzinger A Int J Cancer; 2019 May; 144(9):2303-2312. PubMed ID: 30446996 [TBL] [Abstract][Full Text] [Related]
4. Designing gene panels for tumor mutational burden estimation: the need to shift from 'correlation' to 'accuracy'. Wu HX; Wang ZX; Zhao Q; Wang F; Xu RH J Immunother Cancer; 2019 Aug; 7(1):206. PubMed ID: 31387639 [TBL] [Abstract][Full Text] [Related]
5. Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing. Zhou C; Chen S; Xu F; Wei J; Zhou X; Wu Z; Zhao L; Liu J; Guo W Ann Transl Med; 2021 Sep; 9(18):1437. PubMed ID: 34733989 [TBL] [Abstract][Full Text] [Related]
6. Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis. Li D; Wang D; Johann DJ; Hong H; Xu J Exp Biol Med (Maywood); 2023 Nov; 248(21):1918-1926. PubMed ID: 38062992 [TBL] [Abstract][Full Text] [Related]
7. A scalable solution for tumor mutational burden from formalin-fixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay. Chaudhary R; Quagliata L; Martin JP; Alborelli I; Cyanam D; Mittal V; Tom W; Au-Young J; Sadis S; Hyland F Transl Lung Cancer Res; 2018 Dec; 7(6):616-630. PubMed ID: 30505706 [TBL] [Abstract][Full Text] [Related]
8. Tumor mutational burden quantification from targeted gene panels: major advancements and challenges. Fancello L; Gandini S; Pelicci PG; Mazzarella L J Immunother Cancer; 2019 Jul; 7(1):183. PubMed ID: 31307554 [TBL] [Abstract][Full Text] [Related]
9. Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making. Sun D; Xu M; Pan C; Tang H; Wang P; Wu D; Luo H Front Oncol; 2022; 12():972972. PubMed ID: 36425562 [TBL] [Abstract][Full Text] [Related]
10. Assessment of tumor mutation burden calculation from gene panel sequencing data. Xu Z; Dai J; Wang D; Lu H; Dai H; Ye H; Gu J; Chen S; Huang B Onco Targets Ther; 2019; 12():3401-3409. PubMed ID: 31123404 [No Abstract] [Full Text] [Related]
11. Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB. Sung MT; Wang YH; Li CF Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563486 [TBL] [Abstract][Full Text] [Related]
12. Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project. Vega DM; Yee LM; McShane LM; Williams PM; Chen L; Vilimas T; Fabrizio D; Funari V; Newberg J; Bruce LK; Chen SJ; Baden J; Carl Barrett J; Beer P; Butler M; Cheng JH; Conroy J; Cyanam D; Eyring K; Garcia E; Green G; Gregersen VR; Hellmann MD; Keefer LA; Lasiter L; Lazar AJ; Li MC; MacConaill LE; Meier K; Mellert H; Pabla S; Pallavajjalla A; Pestano G; Salgado R; Samara R; Sokol ES; Stafford P; Budczies J; Stenzinger A; Tom W; Valkenburg KC; Wang XZ; Weigman V; Xie M; Xie Q; Zehir A; Zhao C; Zhao Y; Stewart MD; Allen J; Ann Oncol; 2021 Dec; 32(12):1626-1636. PubMed ID: 34606929 [TBL] [Abstract][Full Text] [Related]
13. Optimizing panel-based tumor mutational burden (TMB) measurement. Budczies J; Allgäuer M; Litchfield K; Rempel E; Christopoulos P; Kazdal D; Endris V; Thomas M; Fröhling S; Peters S; Swanton C; Schirmacher P; Stenzinger A Ann Oncol; 2019 Sep; 30(9):1496-1506. PubMed ID: 31268125 [TBL] [Abstract][Full Text] [Related]
14. Influence of low tumor content on tumor mutational burden estimation by whole-exome sequencing and targeted panel sequencing. Zhang W; Wang R; Fang H; Ma X; Li D; Liu T; Chen Z; Wang K; Hao S; Yu Z; Chang Z; Na C; Wang Y; Bai J; Zhang Y; Chen F; Li M; Chen C; Wei L; Li J; Chang X; Qu S; Yang L; Huang J Clin Transl Med; 2021 May; 11(5):e415. PubMed ID: 34047470 [TBL] [Abstract][Full Text] [Related]
15. The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel. Zhuang W; Ma J; Chen X; Wang G; Lu J; Chen Y; Dong H; Cai S; Zhang Y; Zhao X; Zhu Y; Xu C; Huang Y; Huang Z; Zhu X; Jiang H; Wang Z J Cancer; 2018; 9(13):2302-2307. PubMed ID: 30026825 [No Abstract] [Full Text] [Related]
16. Tumour mutational burden is overestimated by target cancer gene panels. Fang H; Bertl J; Zhu X; Lam TC; Wu S; Shih DJH; Wong JWH J Natl Cancer Cent; 2023 Mar; 3(1):56-64. PubMed ID: 39036316 [TBL] [Abstract][Full Text] [Related]
17. Harmonizing tumor mutational burden analysis: Insights from a multicenter study using in silico reference data sets in clinical whole-exome sequencing (WES). Yu L; Zhang Y; Wang D; Li L; Zhang R; Li J Am J Clin Pathol; 2024 May; ():. PubMed ID: 38733635 [TBL] [Abstract][Full Text] [Related]
18. Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non-Small-Cell Lung Cancer. Vokes NI; Liu D; Ricciuti B; Jimenez-Aguilar E; Rizvi H; Dietlein F; He MX; Margolis CA; Elmarakeby HA; Girshman J; Adeni A; Sanchez-Vega F; Schultz N; Dahlberg S; Zehir A; Jänne PA; Nishino M; Umeton R; Sholl LM; Van Allen EM; Hellmann MD; Awad MM JCO Precis Oncol; 2019; 3():. PubMed ID: 31832578 [TBL] [Abstract][Full Text] [Related]
19. Methods of measurement for tumor mutational burden in tumor tissue. Meléndez B; Van Campenhout C; Rorive S; Remmelink M; Salmon I; D'Haene N Transl Lung Cancer Res; 2018 Dec; 7(6):661-667. PubMed ID: 30505710 [TBL] [Abstract][Full Text] [Related]
20. Standardization of pleural effusion-based tumor mutation burden (TMB) estimation using capture-based targeted sequencing. Yu Y; Shen L; Ji W; Lu S Ann Transl Med; 2021 Jan; 9(2):140. PubMed ID: 33569442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]